Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW) PT Lowered to $85 at RBC Capital

July 25, 2024 6:32 AM
RBC Capital analyst Shagun Singh lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $101.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles